190 related articles for article (PubMed ID: 36499070)
1. Carboxymethyl-Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles for Drug Delivery: Influence of the Coating Thickness on the Particle Properties.
Turrina C; Milani D; Klassen A; Rojas-González DM; Cookman J; Opel M; Sartori B; Mela P; Berensmeier S; Schwaminger SP
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499070
[TBL] [Abstract][Full Text] [Related]
2. Application of magnetic iron oxide nanoparticles: Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles.
Turrina C; Schoenen M; Milani D; Klassen A; Rojas Gonzaléz DM; Cvirn G; Mela P; Berensmeier S; Slabu I; Schwaminger SP
Colloids Surf B Biointerfaces; 2023 Aug; 228():113428. PubMed ID: 37379701
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery.
Unterweger H; Tietze R; Janko C; Zaloga J; Lyer S; Dürr S; Taccardi N; Goudouri OM; Hoppe A; Eberbeck D; Schubert DW; Boccaccini AR; Alexiou C
Int J Nanomedicine; 2014; 9():3659-76. PubMed ID: 25120363
[TBL] [Abstract][Full Text] [Related]
4. Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery.
Turrina C; Cookman J; Bellan R; Song J; Paar M; Dankers PYW; Berensmeier S; Schwaminger SP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834098
[TBL] [Abstract][Full Text] [Related]
5. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages.
Saito S; Tsugeno M; Koto D; Mori Y; Yoshioka Y; Nohara S; Murase K
Int J Nanomedicine; 2012; 7():5415-21. PubMed ID: 23091384
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethylated dextran-coated magnetic iron oxide nanoparticles for regenerable bioseparation.
Li J; Zhou Y; Li M; Xia N; Huang Q; Do H; Liu YN; Zhou F
J Nanosci Nanotechnol; 2011 Nov; 11(11):10187-92. PubMed ID: 22413363
[TBL] [Abstract][Full Text] [Related]
7. High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles.
Shaterabadi Z; Nabiyouni G; Soleymani M
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():947-956. PubMed ID: 28415550
[TBL] [Abstract][Full Text] [Related]
8. Bare Iron Oxide Nanoparticles as Drug Delivery Carrier for the Short Cationic Peptide Lasioglossin.
Turrina C; Berensmeier S; Schwaminger SP
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33923229
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
10. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
11. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides.
Paul KG; Frigo TB; Groman JY; Groman EV
Bioconjug Chem; 2004; 15(2):394-401. PubMed ID: 15025537
[TBL] [Abstract][Full Text] [Related]
13. Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers.
Saxena N; Agraval H; Barick KC; Ray D; Aswal VK; Singh A; Yadav UCS; Dube CL
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110792. PubMed ID: 32279785
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Biocompatible Superparamagnetic Iron Oxide Nanoparticles (SPION) under Different Microfluidic Regimes.
Schemberg J; Abbassi AE; Lindenbauer A; Chen LY; Grodrian A; Nakos X; Apte G; Khan N; Kraupner A; Nguyen TH; Gastrock G
ACS Appl Mater Interfaces; 2022 Oct; 14(42):48011-48028. PubMed ID: 36223272
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
16. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
[TBL] [Abstract][Full Text] [Related]
17. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethyl dextran-trimethyl chitosan coated superparamagnetic iron oxide nanoparticles: An effective siRNA delivery system for HIV-1 Nef.
Kamalzare S; Noormohammadi Z; Rahimi P; Atyabi F; Irani S; Tekie FSM; Mottaghitalab F
J Cell Physiol; 2019 Nov; 234(11):20554-20565. PubMed ID: 31144311
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
[TBL] [Abstract][Full Text] [Related]
20. Chromenone-conjugated magnetic iron oxide nanoparticles. Toward conveyable DNA binders.
Yousuf S; Enoch IVMV; Paulraj MS; Dhanaraj P
Colloids Surf B Biointerfaces; 2015 Nov; 135():448-457. PubMed ID: 26280819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
